Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) EBT Margin (2016 - 2026)

United Therapeutics' EBT Margin history spans 17 years, with the latest figure at 56.19% for Q4 2025.

  • On a quarterly basis, EBT Margin rose 231.0% to 56.19% in Q4 2025 year-over-year; TTM through Dec 2025 was 53.85%, a 36.0% increase, with the full-year FY2025 number at 53.85%, up 36.0% from a year prior.
  • EBT Margin hit 56.19% in Q4 2025 for United Therapeutics, up from 54.78% in the prior quarter.
  • Over the last five years, EBT Margin for UTHR hit a ceiling of 66.83% in Q1 2022 and a floor of 8.57% in Q1 2021.
  • Historically, EBT Margin has averaged 49.11% across 5 years, with a median of 52.6% in 2024.
  • Biggest five-year swings in EBT Margin: crashed -3959bps in 2021 and later skyrocketed 5826bps in 2022.
  • Tracing UTHR's EBT Margin over 5 years: stood at 33.84% in 2021, then rose by 8bps to 36.38% in 2022, then soared by 32bps to 48.06% in 2023, then increased by 12bps to 53.88% in 2024, then rose by 4bps to 56.19% in 2025.
  • Business Quant data shows EBT Margin for UTHR at 56.19% in Q4 2025, 54.78% in Q3 2025, and 51.14% in Q2 2025.